Live
Every GreenBiotech Just Hit Fast Forward. Is Europe’s Seed Sector Ready? - seedworld.comIlluminaCorvex Funds tied to Illumina (NASDAQ: ILMN) sell shares and partly unwind equity swaps - Stock TitanFierceBiotechChutes & Ladders—AC Immune CEO bids adieuClinical OMICsAI in Healthcare: Symposium InsightsFierceBiotechSignant Health buys Ametris to unite data streams in clinical trialsScienceDid this scientist go too far trying to save Ecuador’s wildlife?Endpoints NewsEncoded's gene therapy reduced seizures in Dravet syndromeClinical OMICsA Retina’s Biological Age Can Predict Osteoporosis RiskClinical OMICsWireless Stress Detector Offers Multiple Medical UsesEndpoints NewsASGCT dispatch: In vivo CAR-T is everywhere, but still preclinicalClinical OMICsPrior Heart Attack Linked to Faster Cognitive Decline Over TimeBioPharma DiveCreate Medicines raises $122M to bolster in vivo CAR-T therapies
FierceBiotech Mar 30, 2026

Astellas axes early Sjögren’s trial in latest setback for autoimmune disease community

Astellas axes early Sjögren’s trial in latest setback for autoimmune disease community

Original
Body unavailable. Use the original source.